Richard is a post-doctoral fellow in the NYU Langone Centre for Psychedelic Medicine. He completed his Ph.D. in Clinical Psychology at the Toronto Metropolitan University and his clinical residency at the Centre for Addiction and Mental Health. His research focuses on enhancing mental health treatments for individuals with complex clinical presentations by (a) examining therapeutic mechanisms of change using a multi-method approach (e.g., self-report, idiographic, clinical, physiological, and neurobiological measurement) and (b) integrating psychotherapies with novel pharmacological interventions (e.g., psilocybin, MDMA). Richard has experience providing cognitive behavioural therapy, dialectical behaviour therapy, and emotion-focused therapy for individuals with a range of clinical presentations (e.g., posttraumatic stress disorder, anxiety disorders, and borderline personality disorder). He is also a study therapist in an ongoing clinical trial examining MDMA-facilitated cognitive processing therapy for posttraumatic stress disorder.